Stock Scorer

Astera Labs, Inc. (ALAB)

Astera Labs, Inc. reported revenue of 392.4M USD for the quarter ending 30 June 2026, up 104.5% from 191.9M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 392.4M +104.5%
Gross Profit Q2 '26 · ending 30 June 2026 287.6M +97.6%
Operating Income Q2 '26 · ending 30 June 2026 89.2M +124.4%
Net Income Q2 '26 · ending 30 June 2026 153.1M +198.9%
Cost of Revenue Q2 '26 · ending 30 June 2026 104.8M +126.1%
Operating Cash Flow Q2 '26 · ending 30 June 2026 87.7M -35.2%
Free Cash Flow Q2 '26 · ending 30 June 2026 67.2M -49.6%
Shares Outstanding Q2 '26 · ending 30 June 2026 183.3M +2.9%
EPS Q2 '26 · ending 30 June 2026 2.02 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 852.5M173.4M219.1M281.8M
20242024-12-31 396.3M-116.1M-83.4M102.4M
20232023-12-31 115.8M-29.5M-26.3M-15.5M
20222022-12-31 79.9M-60.2M-58.3M-39.8M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-30392.4M
Q1 '262026-03-31308.4M
Q4 '252025-12-31270.6M
Q3 '252025-09-30230.6M
Q2 '252025-06-30191.9M
Q1 '252025-03-31159.4M
Q4 '242024-12-31141.1M
Q3 '242024-09-30113.1M
Q2 '242024-06-3076.8M
Q1 '242024-03-3165.3M
Q4 '232023-12-3150.5M
Q3 '232023-09-3036.9M
Q2 '232023-06-3010.7M
Q1 '232023-03-3117.7M

Gross Profit Quarterly

PeriodEndingGross Profit
Q2 '262026-06-30287.6M
Q1 '262026-03-31235.1M
Q4 '252025-12-31204.5M
Q3 '252025-09-30175.8M
Q2 '252025-06-30145.6M
Q1 '252025-03-31119.4M
Q4 '242024-12-31104.4M
Q3 '242024-09-3087.9M
Q2 '242024-06-3059.9M
Q1 '242024-03-3150.5M
Q4 '232023-12-3139M
Q3 '232023-09-3028.1M
Q2 '232023-06-308.4M
Q1 '232023-03-314.3M

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-3089.2M
Q1 '262026-03-3161.8M
Q4 '252025-12-3167M
Q3 '252025-09-3055.4M
Q2 '252025-06-3039.8M
Q1 '252025-03-3111.3M
Q4 '242024-12-31144K
Q3 '242024-09-30-8.9M
Q2 '242024-06-30-24.3M
Q1 '242024-03-31-83M
Q4 '232023-12-319M
Q3 '232023-09-30-2M
Q2 '232023-06-30-17.6M
Q1 '232023-03-31-18.9M

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30153.1M
Q1 '262026-03-3180.3M
Q4 '252025-12-3145M
Q3 '252025-09-3091.1M
Q2 '252025-06-3051.2M
Q1 '252025-03-3131.8M
Q4 '242024-12-3124.7M
Q3 '242024-09-30-7.6M
Q2 '242024-06-30-7.5M
Q1 '242024-03-31-93M
Q4 '232023-12-3114.3M
Q3 '232023-09-30-3.1M
Q2 '232023-06-30-20M
Q1 '232023-03-31-17.5M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '262026-06-30104.8M
Q1 '262026-03-3173.2M
Q4 '252025-12-3166.1M
Q3 '252025-09-3054.8M
Q2 '252025-06-3046.4M
Q1 '252025-03-3140M
Q4 '242024-12-3136.6M
Q3 '242024-09-3025.2M
Q2 '242024-06-3017M
Q1 '242024-03-3114.7M
Q4 '232023-12-3111.5M
Q3 '232023-09-308.8M
Q2 '232023-06-302.2M
Q1 '232023-03-3113.4M

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-3087.7M
Q1 '262026-03-3174.6M
Q4 '252025-12-3195.3M
Q3 '252025-09-3078.2M
Q2 '252025-06-30135.4M
Q1 '252025-03-3110.5M
Q4 '242024-12-3139.7M
Q3 '242024-09-3063.5M
Q2 '242024-06-3029.8M
Q1 '242024-03-313.7M
Q4 '232023-12-3114.4M
Q3 '232023-09-30-334K
Q2 '232023-06-30-23M
Q1 '232023-03-31-3.8M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q2 '262026-06-3067.2M
Q1 '262026-03-3167M
Q4 '252025-12-3176.6M
Q3 '252025-09-3065.9M
Q2 '252025-06-30133.3M
Q1 '252025-03-316M
Q4 '242024-12-3124.3M
Q3 '242024-09-3046.8M
Q2 '242024-06-3028.5M
Q1 '242024-03-31228K
Q4 '232023-12-3113.4M
Q3 '232023-09-30-1.1M
Q2 '232023-06-30-23.5M
Q1 '232023-03-31-4.3M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-30183.3M
Q1 '262026-03-31181.2M
Q3 '252025-09-30180.6M
Q2 '252025-06-30178.1M
Q1 '252025-03-31178.1M
Q3 '242024-09-30156.8M
Q2 '242024-06-30155.2M
Q1 '242024-03-3152.5M
Q3 '232023-09-3037.5M
Q2 '232023-06-3036.6M
Q1 '232023-03-3135.8M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-302.02
Q1 '262026-03-311.48
Q4 '252025-12-311.22
Q3 '242024-09-30-1.46
Q2 '242024-06-30-1.49
Q1 '242024-03-31-1.99
Q4 '232023-12-31-0.71